Socioeconomic Challenges Color Patients’ Lung Cancer Screening Experience

New research among lung cancer screening participants has found that low-dose chest computed tomography (CT) screening is generally well tolerated both physically and emotionally, but experiences vary across socioeconomic groups. Lower-income and safety-net participants experienced higher testing-related burden, with factors such as insurance and employment status associated with more discomfort or anxiety. The findingsopens in new tab/window in the Journal of the American College of Radiologyopens in new tab/window, published by Elsevier, highlight opportunities to improve equity in screening.

Lung cancer remains the leading cause of cancer death in the United States, and the early detection of lung cancer saves lives. Participation and long-term adherence to lung cancer screening with low-dose CT remain low in real-world settings.

“Most research has focused on clinical outcomes, with less attention to how patients actually experience the screening test itself,” explains lead investigator Jessica H. Porembka, MD, Department of Radiology, University of Texas Southwestern Medical Center. “We investigated whether patients experience short-term effects, such as discomfort or anxiety, related to lung cancer screening, particularly among underserved populations where barriers to care are greater.”

The investigators conducted a prospective study of 468 lung cancer screening participants across both a university health system and a county safety-net system (serving low-income and marginalized communities), using validated patient-reported measures to assess physical and emotional effects of screening. While overall testing-related burden was very low, a meaningful subset of patients reported discomfort or anxiety.

Safety-net participants reported pain or discomfort more often before and during screening. In multivariable analysis, marital status, employment, and insurance coverage were associated with testing-related burden.

Dr. Porembka points out, “Lung cancer screening saves lives, but it only works if patients return year after year. Even small, temporary burdens from screening may influence whether people come back for annual exams—an essential component of screening effectiveness.”

The study’s findings point to opportunities for targeted interventions, such as:

• Reducing pre-test anxiety

• Improving the physical screening experience

• Addressing structural barriers in underserved settings

This work is among the first to use a validated instrument to quantify the impact of lung cancer screening and to examine how healthcare setting and social determinants of health influence patient experience. Understanding these factors is essential to improving both adherence and equity in lung cancer screening.

Co-investigator and Editor-in-Chief of the Journal of the American College of Radiology Ruth Carlos, MD, MS, Department of Radiology, Columbia University Irving Medical Center, Vagelos College of Physicians and Surgeons, concludes, “We were reassured that overall testing burden was low, suggesting the exam itself is not a major barrier for most patients. At the same time, it was notable that differences in patient experience were closely linked to social and economic factors, reinforcing the importance of a more patient-centered and equity-focused approach to screening.”

Notes for editors

The article is“Patient-Reported Testing Burden of Low-Dose Chest CT Among Lung Cancer Screening Participants,” by Jessica H. Porembka, MD, Yin Xi, PhD, David E. Gerber, MD, Cecelia Brewington, MD, and Ruth Carlos, MD, MS (https://doi.org/10.1016/j.jacr.2026.05.017opens in new tab/window. It appears online ahead of the Journal of the American College of Radiology, volume 23, issue 8 (August 2026) published by Elsevier.

The article is openly available for 60 days at https://www.jacr.org/article/S1546-1440(26)00280-2/fulltextopens in new tab/window.

Full text of this article is also available to credentialed journalists upon request; contact Eileen Leahy at +1 732 406 1313 or [email protected]opens in new tab/window. Journalists wishing to interview the authors should contact Nicole Racadag, Manager, Publications, American College of Radiology, at +1 703 476 7487 or [email protected]opens in new tab/window.

This study was supported by Canon Medical Systems USA, Inc./Radiological Society of North America Research Seed Grant (RSD2201 RO) and supported in part by the Cancer Prevention and Research Institute of Texas (CPRIT; PP230041).

About the Journal of the American College of Radiology

The official journal of the American College of Radiologyopens in new tab/window, JACRopens in new tab/window informs its readers of timely, pertinent, and important topics affecting the practice of diagnostic radiologists, interventional radiologists, medical physicists, and radiation oncologists. The journal’s goals are to improve patient care, support the practice of radiology and imaging, and move the science forward in health services research and policy, clinical practice management, data science, training and education, and leadership. www.jacr.orgopens in new tab/window

About Elsevier

Elsevier is a global leader in advanced information and decision support. For over a century, we have been helping advance science and healthcare to advance human progress. We support academic and corporate research communities, doctors, nurses, future healthcare professionals, and educators across 170 countries in their vital work. We help impact makers achieve better outcomes with research and clinical-grade solutions built on the world’s leading evidence-based scientific and medical content, precision AI, and expert human assessment. We champion inclusion and sustainability, working with the communities that we serve. The Elsevier Foundationopens in new tab/window supports research and health partnerships around the world.

Elsevier is part of RELXopens in new tab/window, a global provider of information-based analytics and decision tools for professional and business customers. For more information, visit www.elsevier.com and follow us on social media @elsevierconnect.